Torthaí cuardaigh - Allison O’Connell

  • 1 - 6 toradh as 6 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy

    Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy de réir David J. Zahavi, Dalal Aldeghaither, Allison O’Connell, Louis M. Weiner

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung Cancer

    Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung Cancer de réir Adrian G. Sacher, Cloud P. Paweletz, Suzanne E. Dahlberg, Ryan S. Alden, Allison O’Connell, Nora Feeney, Stacy L. Mach, Pasi A. Jänne, Geoffrey R. Oxnard

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    A Mechanism of Resistance to Antibody-Targeted Immune Attack

    A Mechanism of Resistance to Antibody-Targeted Immune Attack de réir Dalal Aldeghaither, David J. Zahavi, Joseph C. Murray, Elana J. Fertig, Garrett T. Graham, Yongwei Zhang, Allison O’Connell, Junfeng Ma, Sandra A. Jablonski, Louis M. Weiner

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Noninvasive Detection of Response and Resistance in <i>EGFR</i>-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

    Noninvasive Detection of Response and Resistance in <i>EGFR</i>-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA de réir Geoffrey R. Oxnard, Cloud P. Paweletz, Yanan Kuang, Stacy L. Mach, Allison O’Connell, Melissa M. Messineo, Jason J. Luke, Mohit Butaney, Paul T. Kirschmeier, David M. Jackman, Pasi A. Jänne

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

    Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients de réir Cloud P. Paweletz, Adrian G. Sacher, Chris K. Raymond, Ryan S. Alden, Allison O’Connell, Stacy L. Mach, Yanan Kuang, Leena Gandhi, Paul T. Kirschmeier, Jessie M. English, Lee P. Lim, Pasi A. Jänne, Geoffrey R. Oxnard

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial

    A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial de réir Masahiko Yanagita, Amanda J. Redig, Cloud P. Paweletz, Suzanne E. Dahlberg, Allison O’Connell, Nora Feeney, Myriam Taibi, David Boucher, Geoffrey R. Oxnard, Bruce E. Johnson, Daniel B. Costa, David M. Jackman, Pasi A. Jänne

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: